SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Cadus Pharmaceutical Corp. (KDUS)
An SI Board Since February 1998
Posts SubjectMarks Bans Symbol
1833 48 0 KDUS
Emcee:  Dave K Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
608No argument over not caring about the current share price which doesn't reflTomato-10/24/2001
607You know my position....... if Glass sells it for a nice premium to the cash, wscaram(o)uche-10/24/2001
606I just thank my lucky stars that Glass is spending half his working hours workinTomato-10/24/2001
605finance.yahoo.com^IXIC&d=c&k=c1&c=KDUS&a=v&p=s&t=2y&scaram(o)uche-10/24/2001
604Found the post in question: Message 15864705Tomato-10/24/2001
603cadaver........ not funny. Well, maybe just a little. Kay, as in pink cadiscaram(o)uche-10/24/2001
602Point of Order: Is Cadus pronounced "kah-dus" or "kay-dus"?Tomato-10/24/2001
601gotta get me one of those bulletin board market maker jobs (eom)scaram(o)uche-10/24/2001
600Monday October 22, 12:02 am Eastern Time Press Release SOURCE: Axiom Biotechnoscaram(o)uche-10/22/2001
599links to all three, including the profiling assay that they haven't publicizscaram(o)uche-10/20/2001
598Here's the abstract from WO0171350............. Methods of registering trascaram(o)uche-10/20/2001
597<i>Axiom Biotechnologies today announced that it had been issued two U. S.scaram(o)uche-10/20/2001
596ooooops, wrong thread....... should be NBSC, sorry. (eom)scaram(o)uche-10/20/2001
595INSULIN AND IGF-1 RECEPTOR AGONISTS AND ANTAGONISTS Patent Number: scaram(o)uche-10/20/2001
594emphasis mine, no fixed font with intent........ Thursday October 18, 6:40 am Escaram(o)uche-10/19/2001
593go to........ axiombio.com select "technology" and scroll down to &qscaram(o)uche-10/17/2001
592Nice. A reminder that Biacore has no rights to plug-flow cytometry.......... Tscaram(o)uche-10/16/2001
591Yeah, thats it! And that inhalation microbe that allows an army Ranger to operajayhawk969-10/10/2001
590I'm pretty certain that, before they sold certain assets to OSI, Cadus had iscaram(o)uche-10/10/2001
589I was wrong. Initiation of a phase I trial by Solvay will not trigger a milestoscaram(o)uche-10/9/2001
588UBS Warburg....... 800-759-8603, select #2, then #6, then #5........... &quscaram(o)uche-10/9/2001
587Sometimes authors take awhile with manuscripts. Sometimes a paper will be sent scaram(o)uche-10/8/2001
586Rick: My notes indicate Biacore held 1,333,333 shares of Axiom. So, if Axiom is BulbaMan-10/8/2001
585Rick, I had thought that Cadus ceased operations before the publication of this John Metcalf-10/8/2001
584Mol Genet Genomics 2001 Aug;265(6):1120-8 Genetic selectscaram(o)uche-10/7/2001
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News